Clinical Trials Sponsored by DUSA Pharmaceuticals Inc

Total 5569 results

Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Replicate Food Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lansoprazole 30 mg DR Capsule Fasting Study

Healthy

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

Acne Vulgaris

United States, Belize
Teva Pharmaceuticals USA

Completed

Anastrozole 1 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Anastrozole 1 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pravastatin Sodium 80 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine 25 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Cilostazol 50 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Lamotrigine 25 mg Chewable Tablets, Non-Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Metformin ER 750 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Finasteride 5 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Desmopressin Acetate 0.2 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Finasteride 5 mg Tablets, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ropinirole 0.25 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Glimepiride 4 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cilostazol 100 mg Tablet Formulations Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ribavirin 200 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ursodiol 500 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ursodiol Tablets 500 mg Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Trandolapril 4 mg Tablet Under Fasting Conditions

Healthy

Canada

Clinical Trials Sponsored by DUSA Pharmaceuticals Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations